@article{HBSN30984,
author = {Michael P. Johnston and Janisha Patel and Christopher D. Byrne},
title = {Diabetes is associated with increased risk of hepatocellular carcinoma in non-alcoholic steatohepatitis with cirrhosis—implications for surveillance and future pharmacotherapy},
journal = {Hepatobiliary Surgery and Nutrition},
volume = {9},
number = {2},
year = {2019},
keywords = {},
abstract = {Hepatocellular carcinoma (HCC) is the most common liver-related complication seen in patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) (1). NASH is strongly associated with type 2 diabetes mellitus (T2DM) but it has also been apparent for a number of years that T2DM is associated with an increased risk of HCC independent of the presence of NASH (2).},
issn = {2304-389X}, url = {https://hbsn.amegroups.org/article/view/30984}
}